Introduction to Microbial Evaluation of Compressed Air
A suitable microbial evaluation of compressed air and gases helps determine whether the supplied air or gas is microbiologically controlled at designated points of use. The evaluation generally involves controlled sampling, microbiological examination, incubation, enumeration of microorganisms, and, where required by the approved procedure or specification, examination for specified microorganisms.
Compressed air is widely used in pharma. In pharmaceutical compressed air qualification is mandatory. Along with this, Water Microbial Limit Test is also very important.
What Is Microbial Evaluation of Compressed Air and Gases?
Microbial evaluation of compressed air or process gases is a microbiological examination performed to assess the presence and level of viable microorganisms in the gas supplied to a manufacturing area.
Unlike ordinary environmental monitoring, compressed-air sampling requires the gas itself to be captured or directed through an appropriate sampling arrangement. The collected sample can then be examined using a validated microbiological method.
The evaluation may include:
- Total viable microbial count
- Examination for specified microorganisms, when applicable
- Appropriate positive and negative controls
- Documentation of sampling conditions
- Identification of the sampling point and equipment
- Recording of incubation and test results
- Review and approval of the final microbiological report
Why Is Compressed Air Microbiological Testing Required?
Compressed air is generated outside the point where it is ultimately used. During generation, compression, storage, distribution, and delivery, contamination can potentially be introduced through the system or its components.
Microbiological monitoring can therefore provide useful information about the condition and control of the compressed-air or gas distribution system.
Important reasons for performing the evaluation include:
- Monitoring microbiological quality at selected points of use.
- Detecting deterioration or loss of control in the compressed-air system.
- Supporting contamination-control programs.
- Verifying that microbiological quality remains within an approved specification.
- Providing documented evidence for routine quality monitoring.
- Supporting investigation when abnormal microbiological results are obtained.
Microbial Evaluation of Compressed Air Importance in Pharmaceutical Manufacturing and GMP
Compressed air and gases can become part of the manufacturing process, depending on their application. The microbiological risk consequently depends on factors such as:
- Where the gas is used.
- Whether it contacts the product.
- Whether it contacts a product-contact surface.
- The stage of manufacturing.
- The design and maintenance of the distribution system.
- Filtration and other contamination-control measures.
- The nature of the manufactured product.
Regulatory and GMP Expectations
The source document provides a defined internal procedure for sampling, testing, reporting, controls, and routine frequency. However, it does not identify a specific external regulatory standard supporting every numerical limit or test condition in the procedure.
The approved procedure should clearly define:
- The compressed air or gas systems covered.
- The sampling locations.
- Sampling frequency.
- Sampling volume.
- Sampling equipment and configuration.
- Microbiological test method.
- Culture media and incubation conditions.
- Acceptance criteria.
- Requirements for specified microorganisms, where applicable.
- Positive and negative controls.
- Handling of deviations and atypical results.
Sampling of Compressed Air and Gases
Preparation Before Sampling
Sampling should be performed using controlled microbiological practices.
The source procedure specifies that pre-incubated sampling bottles containing 1% peptone/SCDM are taken to the sampling location. It also requires the sampler to use a face mask and gloves, disinfect the hands with 70% IPA, and disinfect the exterior of the sampling equipment and bottles before use.
Before starting, verify:
- Correct sampling point.
- Sampling point identification.
- Sampling container integrity.
- Sterility status of sampling materials.
- Required sampling volume.
- Calibration/status of the flow-control equipment.
- Availability of required microbiological media.
- Required documentation.
- Appropriate personal protective equipment.
Sampling Procedure
A practical sequence based on the source procedure is:
- Identify the sampling point
Confirm the location and sampling-point identification against the approved sampling plan. - Prepare the sampling equipment
Ensure that the flow meter and associated equipment are clean and suitable for use. - Disinfect the sampling point
Clean the outlet of the compressed-air sampling point according to the approved procedure. - Connect the sampling arrangement
Connect the compressed-air outlet to the flow-meter arrangement. - Allow initial flushing
Start the pressure supply and allow compressed air to drain for the specified period. The source procedure specifies a one-minute drain before sampling. - Set the required flow
The source procedure specifies adjustment of the flow meter to 100 L/min. The actual flow and sampling volume should be based on the approved method and validated sampling arrangement. - Connect the sterile sampling container
Connect the second end of the flow-meter arrangement to the container containing the specified sterile sampling medium. - Collect the sample
Collect the defined volume without compromising the aseptic condition of the sampling system. - Close and identify the sample
Disconnect the container, close it appropriately, and record the sample name, identification, sampling date, and sampler details. - Transfer the sample
Send the sample to the microbiology laboratory promptly under the conditions specified in the approved procedure. - Collect duplicate samples where required
The source procedure specifies duplicate sampling at each point.
Microbiological Testing Procedure
The source procedure specifies that testing is performed under a Laminar Air Flow arrangement. One collected sample is subjected to membrane filtration using a sterile 0.45 µm filter, followed by washing of the filter with 50 mL of sterile 1% peptone/normal saline. The filter is then placed on a pre-incubated SCDA plate and incubated at 30–35 °C for five days.
A simplified workflow is:
Compressed air/gas sampling → Sample transfer → Membrane filtration → Filter washing → Filter placement on culture medium → Incubation → Colony counting → Result calculation/reporting
Calculation and Reporting of Microbial Count
After incubation, the colonies developing on the specified culture medium are counted.
The source procedure expresses the result as CFU per 1,000 litres of compressed air and states that the maximum count obtained on the SCDA plate is considered for reporting.
The laboratory should ensure that the calculation is consistent with the actual sampled volume and the validated method.
For example, where a different sampling volume is used, the result should be converted using the approved calculation:
Microbial concentration = Number of recovered CFU × Reference volume / Actual sampled volume
The calculation and reporting convention should be predefined in the approved SOP.
Testing for Specified Microorganisms
Where specified microorganisms are part of the approved compressed-air monitoring program, the examination should follow validated microbiological procedures.
The source document includes testing sections for several organisms/groups, including:
- Staphylococcus aureus
- Pseudomonas aeruginosa
- Salmonella
- Escherichia coli
- Bile-tolerant Gram-negative bacteria
- Clostridia
- Candida albicans
- Shigella
Acceptance Criteria for Microbial Evaluation of Compressed Air
The source document specifies the following limits:
| Test | Limit stated in source procedure |
|---|---|
| Total microbial count | <10 CFU/1,000 L or <10 CFU/m³ |
| Pathogens | Absent |
Frequency of Sampling
The supplied procedure specifies routine testing on a quarterly basis with a ±5-day allowance.
A suitable monitoring frequency should, however, be established through the site’s approved monitoring program and risk assessment. Frequency may need adjustment when there are:
- Significant maintenance activities.
- Modifications to the compressed-air system.
- Filter replacement.
- Requalification or recommissioning.
- Repeated adverse microbiological trends.
- Deviations or contamination events.
- Changes in manufacturing operations.
Microbial Evaluation of Compressed Air-Practical Implementation in a Pharmaceutical Facility
A compressed-air microbiological monitoring program works best when sampling is integrated with the overall utility and environmental monitoring program.
A practical program can include the following elements:
| Activity | Key consideration |
|---|---|
| Sampling-point selection | Based on system design and process risk |
| Sampling frequency | Defined by approved monitoring plan |
| Sampling method | Validated and documented |
| Sample volume | Scientifically justified and controlled |
| Microbiological test | Approved laboratory method |
| Controls | Positive and negative controls |
| Result evaluation | Compare against approved criteria |
| Trend review | Evaluate repeated or increasing counts |
| Investigation | Required for significant or unexplained results |
| Documentation | Complete traceability from sampling to approval |
Common Mistakes and Challenges during Microbial Evaluation of Compressed Air
Several issues can reduce the reliability of compressed-air microbiological monitoring.
1. Poor Sampling-Point Identification
A sample should always be traceable to a clearly identified point of use. Ambiguous identification can make trending and investigation difficult.
2. Inadequate Sampling Equipment Control
Flow meters and other sampling components should be appropriately controlled, maintained, and calibrated where applicable.
3. Excessive Handling
Unnecessary handling of sterile containers, filters, and connections can introduce contamination.
4. Incorrect Sampling Volume
A result cannot be reliably interpreted if the actual volume of gas sampled is not known or controlled.
Practical Example for Microbial Evaluation of Compressed Air
Consider a compressed-air point used in a tablet compression area.
The approved monitoring plan identifies the point for quarterly microbiological examination. The sampler prepares the sterile sampling assembly, verifies the sampling-point identification, collects the defined gas volume, and transfers the sample to the microbiology laboratory.
The laboratory performs the approved membrane-filtration procedure, incubates the culture medium under the specified conditions, records the recovered CFU, reviews the control results, and compares the result with the approved acceptance criterion.
If the result is within specification and all controls are valid, the result can be documented and included in the microbiological trend.
If the result exceeds the established limit, the laboratory and Quality unit should follow the applicable investigation and impact-assessment procedure.